Ronny Nadiv
Corporate Officer/Principal chez The BWI Business Partnership, Inc.
Postes actifs de Ronny Nadiv
Sociétés | Poste | Début |
---|---|---|
The BWI Business Partnership, Inc.
The BWI Business Partnership, Inc. Miscellaneous Commercial ServicesCommercial Services The BWI Business Partnership, Inc. is a non profit organization provides transportation management for public. The company was founded in 1985 and is headquartered in Linthicum, MD. | Corporate Officer/Principal | - |
The Leukemia & Lymphoma Society, Inc.
The Leukemia & Lymphoma Society, Inc. Miscellaneous Commercial ServicesCommercial Services The Leukemia & Lymphoma Society, Inc. operates as the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services. The firm provides treatment for , lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. It identifies and funds the most promising blood cancer research projects and forges partnerships with academic institutions, biotechnology and pharmaceutical companies to accelerate the development of new therapies. The company is headquartered in Rye Brook, NY. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
The BWI Business Partnership, Inc.
The BWI Business Partnership, Inc. Miscellaneous Commercial ServicesCommercial Services The BWI Business Partnership, Inc. is a non profit organization provides transportation management for public. The company was founded in 1985 and is headquartered in Linthicum, MD. | Commercial Services |
The Leukemia & Lymphoma Society, Inc.
The Leukemia & Lymphoma Society, Inc. Miscellaneous Commercial ServicesCommercial Services The Leukemia & Lymphoma Society, Inc. operates as the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services. The firm provides treatment for , lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. It identifies and funds the most promising blood cancer research projects and forges partnerships with academic institutions, biotechnology and pharmaceutical companies to accelerate the development of new therapies. The company is headquartered in Rye Brook, NY. | Commercial Services |